Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Biosimulation Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Global Cell Line Development Market Size Study, by Product (Immunotherapy Cell Lines, GPCR Cell Lines, Cell Signaling Pathway Cell Lines, Gene Knockout Cell Lines, Ion Channel Cell Lines, Cancer Cell Lines, Others), by Application (Drug Discovery & Development, Basic Research, Toxicity Screening, Biopharmaceutical Production, Tissue Engineering, Forensic Testing), by End-user (Biopharmaceutical Companies, Contract Research Organization, Academic & Research Institutes, Forensic Science Laboratories, Diagnostic Laboratories) and Regional Forecasts 2022-2032
... Discovery & Development, Basic Research, Toxicity Screening, Biopharmaceutical Production, Tissue Engineering, Forensic Testing), by End-user (Biopharmaceutical Companies, Contract Research Organization, Academic & Research Institutes, Forensic Science Laboratories, Diagnostic Laboratories) and Regional Forecasts 2022-2032 Global Cell ... Read More
-
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule, Oral Liquid), Biologics (API, FDF), Packaging & Labelling, Fill-finish), End Users - Global Forecasts to 2029
... manufacturing market is projected to reach USD 319.6 billion by 2029 from USD 200.9 billion in 2024, at a CAGR of 9.7% during the forecast period of 2024 to 2029. The expansion of the pharmaceutical ... Read More
-
Protein Therapeutics
... at a CAGR of 5.8% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$284.7 Billion by the end of ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Legionella Control (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Legionella Control (UK) report will tell you the companies that have ... Read More
-
Global Encephalitis Treatment Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Segment Forecasts, 2023 – 2032 Global Encephalitis Treatment Market was valued at US $20.5 Billion in 2022 and is expected to reach ~US $33 Billion by 2032, growing at a CAGR of 4.8% during the ... Read More
-
Pruritus Therapeutics
... at a CAGR of 4.6% over the analysis period 2023-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$4.7 Billion by the end of the ... Read More
-
Schizophrenia Market Insight, Epidemiology And Market Forecast - 2034
... in diagnosis. During the initial phases of schizophrenia, symptoms lack specificity and coincide with other mental health issues or typical fluctuations in behavior. Disease diagnosis is often delayed due to attached stigma and fear. This ... Read More
-
Multiple Sclerosis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Amyotrophic Lateral Sclerosis
... by 2030, growing at a CAGR of 19.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$285.8 Million While China is Forecast to Grow at 18.4% CAGR The Amyotrophic Lateral Sclerosis market ... Read More
-
Sepsis- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Sepsis: Understanding Sepsis: Overview ... Read More
-
Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024
... Macular Degeneration (Wet AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Rett Syndrome - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024
... polyps pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Global Digital Twin in Healthcare Market Size, Share & Trends Analysis Report, By End-user (Healthcare Providers, Medical Device Companies, Pharmaceutical Companies, and Research Organizations and Academic Institutions), By Application (Healthcare Facility, Medical Device Design and Development, Personalized Diagnosis and Treatment Planning, Drug Discovery and Development, and Others), By Region (North America, Europe, APAC, and Others), and Segment Forecasts, 2023 – 2030
... Development, Personalized Diagnosis and Treatment Planning, Drug Discovery and Development, and Others), By Region (North America, Europe, APAC, and Others), and Segment Forecasts, 2023 – 2030 Global Digital Twin in Healthcare Market Size, Share & ... Read More
-
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030
... and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising cases of autoimmune & neurological disorders and the increasing ... Read More
-
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034
... the 7MM is expected to increase, driven by the launch of emerging therapies. DelveInsight’s analyst projects that among the total diagnosed prevalent cases of myasthenia gravis in 7MM approximately 45% of cases were from the ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
... of Atherosclerotic Cardiovascular Disease in the 7MM is expected to increase, driven by better diagnosis and launch of emerging therapies. DelveInsight’s analyst projects that among the total cases of ASCVD in 7MM approximately 47% of ... Read More
-
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034
... be further sub-divided into B cells, T cells and NK cells. Lymphomas are broadly divided into two major categories: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). When NHL begins in the skin (not in another ... Read More
-
Critical Care Therapeutics
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Albumin Drug Class, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion ... Read More
-
Pneumonia Therapeutics
... at a CAGR of 6.6% over the analysis period 2023-2030. Pneumonia Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of ... Read More
-
Graft versus host disease (GvHD) - Pipeline Insight, 2024
... (GVHD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Kaposi Sarcoma
... at a CAGR of 3.1% over the analysis period 2023-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the ... Read More
-
Krabbe Disease Treatment
... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Anticonvulsants Therapy, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$823.5 Million by ... Read More
Research Assistance
